Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;51(10):837-850.
doi: 10.4070/kcj.2021.0098. Epub 2021 Jul 22.

Late Coronary Aneurysm Formation after Kawasaki Disease: a Review of Mechanistic and Clinical Aspects

Kenan Yalta  1 , Tulin Yalta  2 , Ertan Yetkin  3 , Cihan Ozturk  4
Affiliations
Review

Late Coronary Aneurysm Formation after Kawasaki Disease: a Review of Mechanistic and Clinical Aspects

Kenan Yalta et al. Korean Circ J. 2021 Oct.

Abstract

In patients with Kawasaki disease (KD), evolution of coronary artery aneurysms (CAAs) generally emerges within the first few weeks after disease onset. However, CAA formation in these patients might occasionally arise as a late-onset phenomenon after a long latent period. Characteristically, late CAAs manifest as new-onset vascular pathologies or expansion of long-stable CAAs on coronary imaging modalities, and might have diverse mechanistic and clinical implications. Accordingly, the present paper aims to focus on late CAA formation and its implications in the setting of KD.

Keywords: Aneurysm; Coronary artery; Kawasaki disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Figure 1
Figure 1. Potential mechanisms of late CAA formation in the setting of KD.
CAA = coronary artery aneurysm; KD = Kawasaki disease. *Generally presenting with mild and transient dilatation of coronary arteries.
See this image and copyright information in PMC

References

    1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–e999. - PubMed
    1. Pacheco DA, Miller CR, Boor PJ, Mambo NC. Incomplete Kawasaki disease with development of fatal coronary artery thrombosis in a 13-year-old male. Cardiovasc Pathol. 2019;42:54–58. - PubMed
    1. Pucci A, Martino S, Celeste A, et al. Angiogenesis, tumor necrosis factor-alpha and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease. Cardiovasc Pathol. 2008;17:186–189. - PubMed
    1. Yan ZT, Zou JW. Triptolide as an alternative to IVIG therapy for Kawasaki disease in a mouse model. Balkan Med J. 2013;30:225–228. - PMC - PubMed
    1. Lee CH, Kim U. Coronary artery aneurysm in Kawasaki disease: from multimodality imaging. Coron Artery Dis. 2020;31:193–194. - PubMed